At Systopic, allergy care goes beyond relief — it’s about delivering comfort, affordability, and innovation together.

Welcome to our Anti-Allergic portfolio, where every product is thoughtfully designed to address the diverse needs of patients suffering from allergic conditions. From mild seasonal allergies to persistent allergic rhinitis, we offer comprehensive solutions that ensure effective and sustained relief.

Our portfolio spans across oral antihistamines, advanced combination therapies, and intranasal corticosteroid (INCS) range, enabling a complete approach to allergy management.

We offer trusted molecules like Cetirizine, Levocetirizine, and Fexofenadine, along with clinically relevant combinations such as Levocetirizine + Montelukast and Fexofenadine + Montelukast—ensuring precise and symptom-focused therapy.

Our strong brand portfolio includes: Levosiz-5, Levosiz-10, Levosiz-M, Levosiz-M Kid, AIR 120/180, AIR-M, Sizon, and Sizon Forte. Further strengthening our leadership in allergy management, our INCS range—AIR-FZ and AIR-FZ DUO—offers targeted nasal therapy for patients requiring superior control over allergic rhinitis. With the power of Fluticasone Furoate and the advanced combination with Azelastine, this range addresses both inflammation and symptoms, delivering faster and more effective relief.

As pioneers in the segment, we set a benchmark with the introduction of Levosiz-10, and continue to lead with innovation, especially in the rapidly growing ENT segment.

At Systopic, affordability remains at the core of our philosophy. We are committed to making high-quality, effective allergy treatments accessible to all—without compromising on safety, efficacy, or patient trust.

Because better allergy control means better quality of life.